"The SBA’s COVID Economic Injury Disaster Loan [EIDL] program offers a lifeline to millions of small businesses who are still being impacted by the pandemic. We’ve retooled this critical program – increasing the borrowing limit to $2 million, offering 24 months of deferment, and expanding flexibility."
"EMA’s human medicines committee (CHMP) has approved additional manufacturing sites for the production of Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer. One site, located in Frankfurt am Main, Germany, is operated by Sanofi-Aventis Deutschland GmbH. The other in Hameln, also in Germany, is operated by Siegfried Hameln GmbH.," the statement read on Thursday.
"I have determined that to promote the health and safety of the federal workforce and the efficiency of the civil service, it is necessary to require COVID-19 vaccination for all federal employees, subject to such exceptions as required by law," Biden said.
"It is essential that federal employees take all available steps to protect themselves and avoid spreading COVID-19 to their co-workers and members of the public. The CDC [Centers for Disease Control and Prevention] has found that the best way to do so is to be vaccinated," Biden added.
"The President’s plan will provide additional support for hospitals facing capacity issues. The Department of Defense is announcing a commitment to double the number of DOD teams of clinicians deployed to support hospitals battling a surge in COVID-19 cases. These clinicians will be available for mission assignment through FEMA’s response across surge states," the White House said.
"The Council updated the list of countries, special administrative regions and other entities and territorial authorities for which travel restrictions should be lifted. In particular, Uruguay was added to the list and Albania, Armenia, Azerbaijan, Brunei Darussalam, Japan and Serbia were removed from the list", the council said in a release.
"EMA has already started evaluating an application for a booster dose for Comirnaty, the vaccine developed by Pfizer/BioNTech, for the use of a booster dose to be given at least six months after the second dose in people [aged] 60 years or older", the head of EMA Biological Health Threats and Vaccines Strategy told a press briefing.
"In the week ending September 4, the advance figure for seasonally adjusted initial claims was 310,000, a decrease of 35,000 from the previous week's revised level", the department said in a statement. "This is the lowest level for initial claims since March 14, 2020, when it was 256,000".
"The data continues to move in the positive direction", economist Adam Button said in a post on ForexLive.
"No, we have not received any specific information from our American colleagues so far ... We have to learn in which format it will be held", Peskov told reporters.
"I am pleased to confirm that the COVID-19 vaccines made by Pfizer and AstraZeneca can be used as safe and effective booster doses. This is an important regulatory change as it gives further options for the vaccination programme", said June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA). "It will now be for the (JCVI) to advise on whether booster jabs will be given and if so, which vaccines should be used".
"A state of emergency over the coronavirus remains in force in all prefectures but the prefectures of Miyagi and Okayama until 30 September. Quasi-emergency restrictions remain in place in six prefectures," Suga told a task force meeting, broadcast by NHK.
"We know that increasing vaccinations will stop the spread of the pandemic, will get the pandemic under control, will return people to normal life," White House press secretary Jen Psaki told reporters on Wednesday. "We have more work to do, and we are still at war with the virus."
